doi: 10.1016/0014-2964(78)90308-0.
In vivo studies with hexamethylmelamine
- PMID: 95953
- DOI: 10.1016/0014-2964(78)90308-0
Item in Clipboard
In vivo studies with hexamethylmelamine
Eur J Cancer (1965).
1978 Jun.
No abstract available
Similar articles
-
Distribution, metabolism, and irreversible binding of hexamethylmelamine in mice bearing ovarian carcinoma.Cancer Chemother Pharmacol. 1983;11(1):51-5. doi: 10.1007/BF00257418. Cancer Chemother Pharmacol. 1983. PMID: 6411375
-
In vivo and in vitro irreversible binding of hexamethylmelamine to liver and ovarian tumor macromolecules of mice.Biochem Pharmacol. 1981 May 15;30(10):1151-4. doi: 10.1016/0006-2952(81)90458-5. Biochem Pharmacol. 1981. PMID: 6789835 No abstract available.
-
Hexamethylmelamine and pentamethylmelamine tissue distribution in M5076/73A ovarian cancer-bearing mice.Cancer Treat Rep. 1982 Jan;66(1):127-33. Cancer Treat Rep. 1982. PMID: 6796267
-
Pentamethylmelamine: review of an aqueous analog of hexamethylmelamine.Cancer Treat Rep. 1986 Mar;70(3):383-9. Cancer Treat Rep. 1986. PMID: 3082512 Review.
-
Hexamethylmelamine and hexamethylmelamine hydrochloride.Pharm Weekbl Sci. 1982 Apr 23;4(2):25-31. doi: 10.1007/BF01963657. Pharm Weekbl Sci. 1982. PMID: 6808457 Review.
Cited by
-
Effect of a hepatic activation system on the antiproliferative activity of hexamethylmelamine against human tumor cell lines.Cancer Chemother Pharmacol. 1985;15(1):49-53. doi: 10.1007/BF00257294. Cancer Chemother Pharmacol. 1985. PMID: 3924426
-
The comparative pharmacokinetics of pentamethylmelamine in man, rat, and mouse.Cancer Chemother Pharmacol. 1982;8(1):105-11. doi: 10.1007/BF00292880. Cancer Chemother Pharmacol. 1982. PMID: 6807560
-
Clinical pharmacokinetics of altretamine.Clin Pharmacokinet. 1995 Jun;28(6):439-48. doi: 10.2165/00003088-199528060-00002. Clin Pharmacokinet. 1995. PMID: 7656502 Review.
-
Preclinical toxicology, pharmacokinetics and formulation of N2,N4,N6-trihydroxymethyl-N2,N4,N6-trimethylmelamine (trimelamol), a water-soluble cytotoxic s-triazine which does not require metabolic activation.Cancer Chemother Pharmacol. 1986;17(3):251-8. doi: 10.1007/BF00256694. Cancer Chemother Pharmacol. 1986. PMID: 3091280
-
Melphalan uptake in relation to vascular and extracellular space of human lung-tumour xenografts.Br J Cancer. 1981 Apr;43(4):458-63. doi: 10.1038/bjc.1981.67. Br J Cancer. 1981. PMID: 6263305 Free PMC article.